Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient production and rapid, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company’s flagship product, the Growth Direct® platform, automates and modernizes outdated manual microbial quality control (MQC) testing processes used in the world's largest and most complex pharmaceutical manufacturing operations. The Growth Direct® platform brings quality control laboratories to the manufacturing floor, unleashing the power of inline/online MQC automation, delivering faster results, higher accuracy, improved operational efficiency, better compliance with data integrity regulations, and quicker decision-making to ensure the safe and reliable supply of vital healthcare products that customers depend on.